Search For "biotech"
Nicaragua to start production of Russia's CoviVac vaccine
Updated : 4 years, 4 months ago IST
Managua [Nicaragua], October 21 (ANI/Sputnik): The Mechnikov Institute of Biotechnology in Nicaragua will produce the Russian vaccine against COVID-19, CoviVac, trials have already begun, Laureano Ortega Murillo, Nicaraguan presidential adviser on investment, trade and cooperation, said duri
Read More
As India reaches 100 crore vaccinations, a look at its basket of COVID-19
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): As India achieved the milestone of vaccinating over 100 crore citizens on Thursday, we take look at the basket of vaccines developed, manufactured or in use in the country.
Read More
Administration of ZyCoV-D vaccine requires special training; awaiting NTAG
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the Hy
Read More
Expecting 'one' additional information on Covaxin, decision on emergency u
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 18 (ANI): World Health Organisation (WHO), which is reviewing the data provided by Bharat Biotech for Emergency Use Listing of COVID-19 vaccine Covaxin, said on Monday that it is "expecting one additional piece of information from the company today".
Read More
WHO's advisory group to meet on Oct 26 to consider Covaxin's emergency usa
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 17 (ANI): Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covax
Read More
India to procure over 30 crore COVID-19 vaccine doses per month by January
Updated : 4 years, 5 months ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Read More
Family of black woman suing biotech firm for taking cancer cells without c
Updated : 4 years, 5 months ago IST
Washington [US], October 16 (ANI): The family of an African-American woman, Henrietta Lacks whose cervical cancer cells were taken without consent for research in 1951 is suing a biotech firm for compensation.
Read More
I'm sure approval of Covaxin from WHO will come at soonest possible, says
Updated : 4 years, 5 months ago IST
Bhubaneswar (Odisha) [India], October 15 (ANI): Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.
Read More
Covaxin's approval for children aged 2-18 yrs under experts' opinion, eval
Updated : 4 years, 5 months ago IST
New Delhi [India], October 14 (ANI): The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday.
Read More
Awaiting regulatory approval for rolling out Covaxin for children aged 2-1
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More
Climate change: "India needs to set up solar manufacturing units, prioriti
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): India is at the forefront of making serious efforts towards achieving climate change targets, said Dr Shailja Vaidya Gupta, former Senior Adviser at the Office of the Principal Scientific Adviser to the Government, Adviser Department of Biotechnology and
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More